The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combining the potency of a neoantigen-expressing DNA vector, an anti-CTLA-4 antibody, and an attenuated poxvirus in a personalized immunization platform: Preclinical studies of ODI-2001.
 
Pierre Marschall
Employment - Odimma Therapeutics
Stock and Other Ownership Interests - Odimma Therapeutics
 
Celia Matta
Employment - Odimma Therapeutics
Stock and Other Ownership Interests - Odimma Therapeutics
 
Cécile Hugel
Employment - Odimma Therapeutics
Stock and Other Ownership Interests - Odimma Therapeutics
 
Jessica Matta
Employment - Odimma Therapeutics
Leadership - Odimma Therapeutics
Stock and Other Ownership Interests - Odimma Therapeutics
 
Cedric Bogaert
Employment - myNEO
Leadership - myNEO
Stock and Other Ownership Interests - myNEO
 
François Ghiringhelli
Honoraria - roche
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Roche/Genentech; Roche/Genentech
 
Pascale Balducchi
Employment - Odimma Therapeutics
Leadership - Odimma Therapeutics
Stock and Other Ownership Interests - Odimma Therapeutics
 
Jean-Marc Limacher
Employment - Odimma Therapeutics
Leadership - Odimma Therapeutics
Stock and Other Ownership Interests - Odimma Therapeutics
Patents, Royalties, Other Intellectual Property - Patents
Travel, Accommodations, Expenses - Pfizer